Editas Medicine
Editas Medicine Logo
About Editas Medicine
Editas Medicine Inc is a clinical-stage biotechnology company focused on developing transformative genomic medicines using CRISPR gene editing technology. The company is advancing a pipeline of experimental therapies targeting serious diseases, including sickle cell disease, beta-thalassemia, and various cancers. Editas Medicine's proprietary gene editing platform aims to enable precise molecular modifications for therapeutic benefit. The company collaborates with partners to develop gene-edited cell therapies and is committed to translating genome editing science into novel human therapeutics.
Address
11 Hurley Street,
Cambridge, 02141
United States
Year founded
2013
Number of employees
200-300
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
